Affiliation:
1. Transplant and Oncology Infectious Diseases Johns Hopkins University School of Medicine Baltimore Maryland USA
2. Transplant Surgery Johns Hopkins University School of Medicine Baltimore Maryland USA
3. HIV & AIDS Malignancy Branch, Center for Cancer Research NCI Bethesda Maryland USA
Abstract
AbstractBackgroundHuman herpes virus 8 (HHV‐8) or Kaposi sarcoma herpesvirus (KSHV) is an opportunistic oncovirus that causes multiple pathologic entities.MethodsWe present a case of fatal HHV‐8‐associated multisystem illness with disseminated Kaposi sarcoma and HHV8‐associated lymphoproliferative disorder with systemic inflammation. We conducted a narrative review of the literature on HHV‐8 in transplantation with a goal of illuminating the spectrum of HHV‐8‐associated diseases in this vulnerable population, modes of disease transmission, and the potential role for donor and recipient screening.ResultsHHV‐8‐associated KS, primary effusion lymphoma (PEL), multicentric Castleman disease (MCD), and KSHV inflammatory cytokine disorder (KICS) may affect transplant recipients; with the exception of KS, these conditions are rare but carry high morbidity and mortality.ConclusionHHV‐8‐associated diseases have diverse and protean manifestations in transplant recipients, with potentially fatal outcomes. HHV‐8 seroprevalence among organ donors and the magnitude of risk for donor‐derived HHV‐8 infection or clinically significant disease remain unknown and require further study.
image
Funder
National Cancer Institute